Antimicrobial susceptibilities and clinical sources of Facklamia species - Wikidata - awgldk - TriplyDB

Antimicrobial susceptibilities and clinical sources of Facklamia species

Antimicrobial susceptibilities and clinical sources of Facklamia species

http://www.wikidata.org/entity/Q33980225

about

What happened to the streptococci: overview of taxonomic and nomenclature changes Facklamia Species as an Underrecognized Pathogen DNA relatedness, phenotypic characteristics, and antimicrobial susceptibilities of Globicatella sanguinis strains.Multi-territory ischaemic strokes and subacute bacterial endocarditis.Facklamia Species and Streptococcus pneumoniae Meningitis: A Case Report and Review of the Literature.Differential Analysis of the Nasal Microbiome of Pig Carriers or Non-Carriers of Staphylococcus aureus.Infective endocarditis: a rare organism in an uncommon setting A very unusual organism causing stroke-like symptoms.Ignavigranum ruoffiae, a rare pathogen that caused a skin abscess.

P2860

Q24535684-3D298E22-9837-4F38-A50B-B290D3C11BF9 Q33629168-8606D2F9-9321-4C66-9C83-A214314289EA Q33974031-8480150C-C8DF-4110-8053-94957F495B82 Q34526573-4C09375E-EBE5-4690-995A-E791BC24C9A1 Q36051935-F6C5E66E-CCCA-43A9-A76E-86CCC0D56419 Q36100403-74C5B35C-DACA-4B5A-858C-8C85D3F5CA73 Q36519918-E1E6EABD-87E6-49B7-9B73-E7B12DDE9E75 Q40199791-E3C829CE-81EC-4D91-8109-606194FA2182 Q54250414-69535B76-7A7A-40D2-A37E-3EFD28D3984A

P2860

Antimicrobial susceptibilities and clinical sources of Facklamia species

http://www.wikidata.org/entity/Q33980225

description

2000 nî lūn-bûn

@nan

2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Antimicrobial susceptibilities and clinical sources of Facklamia species

@ast

Antimicrobial susceptibilities and clinical sources of Facklamia species

@en

type

label

Antimicrobial susceptibilities and clinical sources of Facklamia species

@ast

Antimicrobial susceptibilities and clinical sources of Facklamia species

@en

prefLabel

Antimicrobial susceptibilities and clinical sources of Facklamia species

@ast

Antimicrobial susceptibilities and clinical sources of Facklamia species

@en

P1433

Q33980225-35D893F4-EBCE-4091-9F8B-F0C110B87C22

P1476

Q33980225-670F833C-9D0E-47C4-BDAF-29720C4D831E

P2093

Q33980225-75C56950-6FCB-4B9B-A10C-BF27CD4E2152

Q33980225-8EED0BEF-5F3C-4035-9B21-C4D9DF3C8184

P2860

Q33980225-12C2097C-4724-443C-8F49-A5C09637710B

Q33980225-1F774787-646F-4B5E-85EB-3990EDB88220

Q33980225-217A8154-19E8-46ED-9FB3-860E014ADCFF

Q33980225-2BF2D6E9-FEBD-44C5-8ABD-FD69E7DCC5DA

Q33980225-48F6EE29-DC59-424D-AA33-612FE52A6F52

Q33980225-56117F9B-FDC3-433B-89FF-08A89B719DA2

Q33980225-6451CD23-287A-4F19-9BB5-A7E6433E9A58

Q33980225-66583BC5-0846-49FA-B8F9-29217B4C1C3E

Q33980225-84B5B127-E27C-4037-A620-D94BE19C045E

Q33980225-8AAB7A1E-8988-4F39-A72B-B9A5EF70ACD9

P304

Q33980225-86C2767D-C644-489C-8981-F5A548033C3F

P31

Q33980225-79BA73A4-68C9-4745-9974-97AD5A0C1D9F

P356

Q33980225-2F2CC5CD-2038-4AF6-B89F-4CC920FBFDDD

P407

Q33980225-5B0E7571-7F12-4148-87EA-4D916891A974

P433

Q33980225-3F1A71FC-01B6-4490-A8FD-C411B98A1AE4

P478

Q33980225-1BD875A9-59AC-401A-BF5E-7962285A608D

P577

Q33980225-6C5E884D-481D-46FC-AC89-0EB6403502A8

P698

Q33980225-BC78A4A5-A9A6-43A8-8213-59D2AA8F071A

P932

Q33980225-A479AA96-7801-427D-83C1-465664093B79

P356

AAC.44.8.2130-2132.2000

P1433

Antimicrobial Agents and Chemotherapy

P1476

Antimicrobial susceptibilities and clinical sources of Facklamia species

@en

P2093

L LaClaire

http://www.w3.org/2001/XMLSchema#string

R Facklam

http://www.w3.org/2001/XMLSchema#string

P2860

Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States.

Facklamia languida sp. nov., isolated from human clinical specimens.

Facklamia sourekii sp. nov., isolated from human sources.

Facklamia tabacinasalis sp. nov., from powdered tobacco.

Facklamia ignava sp. nov., isolated from human clinical specimens.

Comparison of three commercial rapid identification systems for the unusual gram-positive cocci Dolosigranulum pigrum, Ignavigranum ruoffiae, and Facklamia species.

In vitro activities of fluoroquinolones against antibiotic-resistant blood culture isolates of viridans group streptococci from across Canada.

In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood.

Atmospheric growth requirements for Alloiococcus species and related gram-positive cocci

Phenotypic and phylogenetic characterization of some Globicatella-like organisms from human sources: description of Facklamia hominis gen. nov., sp. nov.

P304

2130-2132

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.44.8.2130-2132.2000

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P577

2000-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10898686

http://www.w3.org/2001/XMLSchema#string

P932

90024

http://www.w3.org/2001/XMLSchema#string